LOGIN
Bupivacaine delivered by elastomeric pumps reduce pain and narcotic consumption after TKA
March 2013
Bupivacaine delivered by elastomeric pumps reduce pain and narcotic consumption after TKA
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A
The 2012 Chitranjan Ranawat award: intraarticular analgesia after TKA reduces pain: a randomized, double-blinded, placebo-controlled, prospective study
Clin Orthop Relat Res. 2013 Jan;471(1):64-75. doi: 10.1007/s11999-012-2596-9Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
160 patients, undergoing total knee arthroplasty, were randomised into two groups to receive either bupivacaine or a placebo through an infusion pump, to measure the short-term outcomes: post-operative pain and need for rescue analgesia. Following assessments over a 3 day period, results indicated that bupivacaine decreased pain, opioid consumption, and opioid-related side effects.
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.